Isoptin News

Ranbaxy’s Q3 PAT increases 48%, stands at Rs 2074mn - Moneycontrol.com (press release)

... Isoptin SR (Verapamil SR), following an acquisition of the product registration from FSC Laboratories, Inc. of Charlotte, North Carolina, USA. ...

http://www.moneycontrol.com/india... | Posted: Thu Oct 18 03:55:23 -0400 2007

Ranbaxy: Tough times - Business Standard

Over the next few quarters, growth for the company is also expected from authorised generics sales for the product Isoptin (medication for treating heart ...

http://www.business-standard.com/... | Posted: Fri Oct 19 11:16:59 -0400 2007

Par Pharmaceutical Swings to 4Q Profit - Forbes

... of FineTech Laboratories, Ltd. and a $9.2 million asset impairment charge related to Par's purchase of the new drug application for Isoptin SR. ...

http://www.forbes.com/feeds/ap/20... | Posted: Thu Sep 06 15:36:17 -0400 2007

Ranbaxy Forays Into Authorized Generics in US With Isotopin SR - Therapeutics Daily (subscription) (press release)

Isoptin SR, a niche value added formulation, also enhances our new drug delivery systems (NDDS) capability and our efforts with other molecules to improve ...

http://www.therapeuticsdaily.com/... | Posted: Tue Jul 31 05:00:35 -0400 2007

India's Ranbaxy Laboratories to sell Isoptin SR in US - ABCmoney.co.uk

Ranbaxy said it has launched Isoptin, used for hypertension and angina treatment, through its full-owned subsidiary Ranbaxy Pharmaceuticals Inc after an ...

http://www.abcmoney.co.uk/news/30... | Posted: Mon Jul 30 04:42:58 -0400 2007

Cluster Headache Drug Can Cause Heart Problems, New Study - Medical News Today

Verapamil (brand names include Isoptin, Verelan, Calan, and Bosoptin) is an "L type calcium channel blocker" and is used to treat a range of symptoms ...

http://www.medicalnewstoday.com/a... | Posted: Tue Aug 14 00:32:30 -0400 2007